WithdrawnNCT00397605
Cannabinoids in Bipolarity
Medication studyAges 19–60Canada
Understand this study
Who could participate?
This study is for people with bipolarity. Listed age limits: 19 years to 60 years. Other eligibility criteria apply.
- Listed locations
- VancouverSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNovember 2006
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- University of British Columbia
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Canada
- Age range
- From 19 Years to 60 Years
- Official registry ID
- NCT00397605
- Official title
Show the full official title
Cannabinoids in Bipolar Affective Disorder: A Controlled Pilot Study
Recruitment & locations
WithdrawnVancouver
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is University of British Columbia, a university.
Does this study involve medication?
Yes. The study involves medication, including Synthetic cannabinoids (1:1 ratio of THC % CBD).
Who can participate?
This study is for people with bipolarity. Listed age limits: 19 years to 60 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as withdrawn.
